• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布劳综合征患者单核细胞刺激后细胞因子谱的改变。

Altered cytokine profiles of mononuclear cells after stimulation in a patient with Blau syndrome.

机构信息

Department of Dermatology, Korea University Medical Center, Seoul, South Korea.

出版信息

Rheumatol Int. 2010 Jun;30(8):1121-4. doi: 10.1007/s00296-009-1342-4. Epub 2010 Jan 6.

DOI:10.1007/s00296-009-1342-4
PMID:20052476
Abstract

Autoinflammatory Blau syndrome (BS) is associated with NOD2 gene mutations that lead to constitutive NFkappaB activation. NOD2 functions as an intracellular receptor for the muramyl dipeptide (MDP) component of peptidoglycan (PGN). The objectives of this study are to analyse whether NFkappaB activation in BS affects immune cell functions, and whether NOD2 and toll-like receptor (TLR) pathways interact. Peripheral blood mononuclear cells (MNCs) from a BS patient and three normal donors were analyzed for their ability to produce pro- and anti-inflammatory cytokines in the presence and absence of MDP, PGN, and lipopolysaccharide (LPS). The results obtained showed that the basal TNF-alpha and IL-10 production by MNCs over 24 h of incubation was very low for both the patient and the normal donors. However, upon stimulation with MDP, LPS, and PGN, the cells from the BS patient produced much lower levels of TNF-alpha, IL-10, G-CSF, and IFN-gamma than the normal donor cells. We conclude that the pathogenic mechanism responsible for the chronic inflammation that characterizes BS may relate to the impaired production of both pro- and anti-inflammatory cytokines to stimuli. The NOD2 pathway possibly interacts with either the TLR2 or TLR4 pathways.

摘要

自身炎症性 Blau 综合征 (BS) 与 NOD2 基因突变相关,这些突变导致 NFkappaB 的组成性激活。NOD2 作为肽聚糖 (PGN) 中 muramyl dipeptide (MDP) 成分的细胞内受体发挥作用。本研究的目的是分析 BS 中 NFkappaB 的激活是否会影响免疫细胞的功能,以及 NOD2 和 Toll 样受体 (TLR) 途径是否相互作用。分析了来自 BS 患者和三名正常供体的外周血单核细胞 (MNC) 在存在和不存在 MDP、PGN 和脂多糖 (LPS) 的情况下产生促炎和抗炎细胞因子的能力。结果表明,BS 患者和正常供体的 MNC 在孵育 24 小时后,TNF-alpha 和 IL-10 的基础产生量非常低。然而,在用 MDP、LPS 和 PGN 刺激后,BS 患者的细胞产生的 TNF-alpha、IL-10、G-CSF 和 IFN-gamma 水平明显低于正常供体细胞。我们得出结论,导致 BS 特征性慢性炎症的致病机制可能与对刺激物的促炎和抗炎细胞因子产生受损有关。NOD2 途径可能与 TLR2 或 TLR4 途径相互作用。

相似文献

1
Altered cytokine profiles of mononuclear cells after stimulation in a patient with Blau syndrome.布劳综合征患者单核细胞刺激后细胞因子谱的改变。
Rheumatol Int. 2010 Jun;30(8):1121-4. doi: 10.1007/s00296-009-1342-4. Epub 2010 Jan 6.
2
Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis.结节病中TLR2和TLR4的单核细胞表达较高,且TLR2与NOD2刺激的促炎协同作用增强。
J Clin Immunol. 2009 Jan;29(1):78-89. doi: 10.1007/s10875-008-9225-0. Epub 2008 Sep 5.
3
NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice.NOD2 缺陷导致小鼠对肽聚糖诱导的葡萄膜炎易感性增加。
Invest Ophthalmol Vis Sci. 2011 Jun 9;52(7):4106-12. doi: 10.1167/iovs.10-6263.
4
MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.MDP 诱导的 TLR4 配体选择性耐受:NOD2 突变型克罗恩病患者的损害。
Inflamm Bowel Dis. 2009 Nov;15(11):1686-96. doi: 10.1002/ibd.21013.
5
NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells.在树突状细胞中,金黄色葡萄球菌衍生的肽聚糖对NOD2的刺激作用会因Toll样受体2与脂蛋白的共刺激而增强。
Infect Immun. 2014 Nov;82(11):4681-8. doi: 10.1128/IAI.02043-14. Epub 2014 Aug 25.
6
Muramyl dipeptide potentiates a Bacillus anthracis poly-γ-d-glutamic acid capsule surrogate that induces maturation and activation of mouse dendritic cells.双孢蘑菇二肽增强炭疽杆菌多聚-γ-D-谷氨酸胶囊替代物诱导的小鼠树突状细胞成熟和激活。
Cytokine. 2018 Oct;110:350-356. doi: 10.1016/j.cyto.2018.04.004. Epub 2018 Apr 12.
7
A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities, resulting in synergistic activation of human monocytic cells.一种聚合物型水溶性肽聚糖表现出Toll样受体2和NOD2激动活性,从而导致人单核细胞的协同激活。
Innate Immun. 2008 Oct;14(5):298-308. doi: 10.1177/1753425908096518.
8
Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2.
Rheumatol Int. 2007 Jan;27(3):257-62. doi: 10.1007/s00296-006-0250-0. Epub 2006 Nov 10.
9
Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.胞壁酰二肽通过成骨细胞中核苷酸结合寡聚化结构域2介导的信号传导增强脂多糖、白细胞介素-1α和肿瘤坏死因子-α诱导的破骨细胞形成。
J Immunol. 2005 Aug 1;175(3):1956-64. doi: 10.4049/jimmunol.175.3.1956.
10
Interleukin-21 enhances Toll-like receptor 2/4-mediated cytokine production via phosphorylation in the STAT3, Akt and p38 MAPK signalling pathways in human monocytic THP-1 cells.白细胞介素-21 通过磷酸化 STAT3、Akt 和 p38 MAPK 信号通路增强人单核细胞 THP-1 细胞中 Toll 样受体 2/4 介导的细胞因子产生。
Scand J Immunol. 2019 Jun;89(6):e12761. doi: 10.1111/sji.12761. Epub 2019 Apr 11.

引用本文的文献

1
Case report and review of the literature: a unique presentation of Blau syndrome in a Palestinian family.病例报告及文献综述:巴勒斯坦一家系中Blau综合征的独特表现
Front Pediatr. 2025 Jul 22;13:1482846. doi: 10.3389/fped.2025.1482846. eCollection 2025.
2
Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.布劳综合征 NOD2 突变导致 NOD2 交叉调节功能丧失。
Front Immunol. 2022 Sep 15;13:988862. doi: 10.3389/fimmu.2022.988862. eCollection 2022.
3
Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.

本文引用的文献

1
The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity.布劳综合征中的NOD2缺陷不会导致白细胞介素-1活性过高。
Arthritis Rheum. 2009 Feb;60(2):611-8. doi: 10.1002/art.24222.
2
Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation.肿瘤坏死因子-α抑制剂(英夫利昔单抗)对一对具有新发CARD15突变的单卵双胞胎布劳综合征的有利影响。
APMIS. 2006 Dec;114(12):912-9. doi: 10.1111/j.1600-0463.2006.apm_522.x.
3
Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2.
TNF 靶向治疗在 NOD2 相关系统性自身炎症性肉芽肿病——布劳综合征中的潜在获益。
Front Immunol. 2022 May 27;13:895765. doi: 10.3389/fimmu.2022.895765. eCollection 2022.
4
T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.Nod2 在 T 细胞内在性保护中抵抗 Th17 介导的葡萄膜炎的作用。
Nat Commun. 2020 Oct 26;11(1):5406. doi: 10.1038/s41467-020-18961-0.
5
Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency.NOD2 相关的 Blau 综合征与 IFNγR1 缺陷的相互改变。
J Clin Immunol. 2020 Jan;40(1):165-178. doi: 10.1007/s10875-019-00720-6. Epub 2019 Nov 23.
6
Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: NOD2, PLCG2 and LACC1.利用基因对肉芽肿性自身炎症性疾病的病理生理学进行三角定位:NOD2、PLCG2 和 LACC1。
Int Immunol. 2018 Apr 25;30(5):205-213. doi: 10.1093/intimm/dxy021.
7
A familial case of Blau syndrome caused by a novel genetic mutation.一例由新型基因突变引起的布劳综合征家族病例。
Korean J Pediatr. 2016 Nov;59(Suppl 1):S5-S9. doi: 10.3345/kjp.2016.59.11.S5. Epub 2016 Nov 30.
8
NLRP12 autoinflammatory disease: a Chinese case series and literature review.NLRP12 自身炎症性疾病:中国病例系列及文献综述
Clin Rheumatol. 2017 Jul;36(7):1661-1667. doi: 10.1007/s10067-016-3410-y. Epub 2016 Sep 16.
9
Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.与布劳综合征相关的Nod2突变改变全长NOD2的表达,并限制了基因敲入小鼠对胞壁酰二肽的反应。
J Immunol. 2015 Jan 1;194(1):349-57. doi: 10.4049/jimmunol.1402330. Epub 2014 Nov 26.
Rheumatol Int. 2007 Jan;27(3):257-62. doi: 10.1007/s00296-006-0250-0. Epub 2006 Nov 10.
4
Functional consequences of NOD2 (CARD15) mutations.NOD2(CARD15)基因突变的功能后果。
Inflamm Bowel Dis. 2006 Jul;12(7):641-50. doi: 10.1097/01.MIB.0000225332.83861.5f.
5
The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders.胞质模式识别受体Nod2与炎性肉芽肿性疾病
J Dermatol Sci. 2005 Aug;39(2):71-80. doi: 10.1016/j.jdermsci.2005.04.001.
6
Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.核苷酸结合寡聚化结构域2调节特定的Toll样受体途径以诱导细胞因子释放。
J Immunol. 2005 May 15;174(10):6518-23. doi: 10.4049/jimmunol.174.10.6518.
7
Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.早发型结节病与伴有组成性核因子-κB激活的CARD15突变:与布劳综合征的共同遗传病因。
Blood. 2005 Feb 1;105(3):1195-7. doi: 10.1182/blood-2004-07-2972. Epub 2004 Sep 30.
8
Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation.存在一例伴有CARD15突变的散发性系统性肉芽肿综合征病例。
J Invest Dermatol. 2004 Mar;122(3):851-2. doi: 10.1111/j.0022-202X.2004.22341.x.
9
Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition.参与胞壁酰二肽识别的NOD2的调控区域和关键残基。
EMBO J. 2004 Apr 7;23(7):1587-97. doi: 10.1038/sj.emboj.7600175. Epub 2004 Mar 25.
10
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.Nod2是一种通过检测胞壁酰二肽(MDP)来识别肽聚糖的通用传感器。
J Biol Chem. 2003 Mar 14;278(11):8869-72. doi: 10.1074/jbc.C200651200. Epub 2003 Jan 13.